Funding · Company
Tune Therapeutics, Inc.
Seattle, WABiotech & Pharma
Tune Therapeutics, Inc. of Seattle, WA has disclosed $182M across 1 Form D offering filed with the SEC on Jan 24, 2025.
$182M
Total disclosed
1
Form D offering
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$182M
Form D · Jan 24, 2025 ↗
Q1 2025
· target $208M
Filing details
HeadquartersSeattle, WAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0002053139Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →